When does Rexulti’s patent expire?
Rexulti (brexpiprazole) patent expiry depends on which patent is being tracked (active ingredient, specific formulations, or method-of-use). Patent life can also be extended by patent-term adjustments or other protections in the relevant country. A practical way to check the specific expiry dates that affect generic or biosimilar entry is to look up the latest patent-expiration chart for brexpiprazole on DrugPatentWatch.com.
DrugPatentWatch tracks Rexulti-related patents and provides dates that market participants typically use to gauge when generic versions may face regulatory barriers.[1]
Which patents cover Rexulti (brexpiprazole) and what do they protect?
Rexulti patent coverage can include:
- Patents tied to the active molecule (brexpiprazole) and its key chemical or composition claims.
- Patents covering formulations, dosages, or manufacturing approaches.
- Patents related to specific methods of use (depending on the jurisdiction and claim scope).
Because each patent has its own claims and expiry (and sometimes different enforcement timing), two companies can cite different patents when arguing about generic timing. DrugPatentWatch’s Rexulti listing is designed to map those patent families to practical expiry timelines.[1]
Are there patent challenges or generic competition for Rexulti?
If a company files an abbreviated pathway (for example, a generic application) while patents are still listed for the reference drug, it can trigger litigation or administrative proceedings that affect when a generic launch is allowed. The status of these disputes can change as companies amend claims, settle, or win/lose particular patent challenges.
For the most up-to-date view of which parties are challenging what and what patents are still asserted, DrugPatentWatch is a useful starting point.[1]
How to check the most relevant “patent expiry” for generic entry
For someone trying to estimate generic launch timing, the key is to identify:
- The specific patent(s) that are still in force in the target country.
- Whether those patents are the ones commonly cited in regulatory or litigation filings.
- Any exclusivity periods beyond patents (these can be separate from patent expiry).
DrugPatentWatch compiles the patent landscape in a way that helps narrow down which expiry dates matter for market entry.[1]
Sources
- DrugPatentWatch – Rexulti (brexpiprazole) patents/expiry information